Endovascular Treatment and RIPC in Acute Ischemic Stroke

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 300 participants.

Also called NCT04581759

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 300 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT04581759
Other papers using this trial's data
  • Remote Ischemic Postconditioning in Endovascular Thrombectomy for Stroke: The EnTRIPS Randomized Clinical Trial Stroke, 2026-08 DOI, PubMed 42267436

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT04581759. Randomized; quadruple masking; primary purpose treatment. Start 2021-04-12 (actual); primary completion 2023-04-30 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Endovascular Treatment and RIPC in Acute Ischemic Stroke
Acronym
EnTRIPS
Condition
Acute Ischemic Stroke
Condition
Endovascular Treatment
Intervention (Device)
RIPC device (IPC-906X)
Intervention (Drug)
foundational treatment
Lead sponsor
First Affiliated Hospital Xi'an Jiaotong University (class: other)
Collaborator
Second Affiliated Hospital of Xi'an Jiaotong University (class: other)
Collaborator
Shaanxi Provincial People's Hospital (class: other)
Collaborator
Xijing Hospital (class: other)
Collaborator
Tang-Du Hospital (class: other)
Collaborator
Xi'an No.3 Hospital (class: other government)
Collaborator
Xi'an Gaoxin Hospital (class: other)

Record details

Record id
cardio:ct-nct04581759
Content hash
00fdd94d265b7374b94e919b3eccce658696f1ffa278f2877c472a956bbcd5ad